Virus-HIV Clinical Trial
— PVVIHOfficial title:
Life Experience of People Aged 60 and Over Living With HIV: Quantitative Sociological Study
| NCT number | NCT05083273 |
| Other study ID # | CHRD1321 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | May 18, 2021 |
| Est. completion date | June 24, 2021 |
| Verified date | June 2021 |
| Source | Centre Hospitalier René Dubos |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of this study is to Assess the impact of HIV on the life course of patients aged 60 and over.
| Status | Completed |
| Enrollment | 225 |
| Est. completion date | June 24, 2021 |
| Est. primary completion date | June 24, 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria : People aged 60 and over living with HIV and view in consultation Patient participation agreement obtained Exclusion criteria : People living with HIV less than 60 years old |
| Country | Name | City | State |
|---|---|---|---|
| France | Hospital Beaujon, Clichy / Médecine Interne | Clichy | |
| France | Hôpital Bichat Claude-Bernard - Service de Maladies Infectieuses et Tropicales | Paris | |
| France | Hôpital Bichat Claude-Bernard -COREVIH Ile de France Nord | Paris | |
| France | Université Paris Descartes - CERMES3 | Paris | |
| France | Centre Hospitalier René Dubos | Pontoise | |
| France | Hospital Delafontaine, Saint-Denis / Maladie infectieuse | Saint-Denis |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier René Dubos |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Determine the impact of HIV in the life cours of people aged 60 and over and the questioning of the future. | People aged 60 and over will answer to a sociological questionnaire to identify the impact of HIV in their life cours and the questioning of the future, directly or indirectly linked to HIV. | Through study completion, an average of 6 month |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04575545 -
Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP
|
||
| Completed |
NCT03195452 -
QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient
|
Phase 2 | |
| Active, not recruiting |
NCT04581746 -
Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
|
N/A | |
| Not yet recruiting |
NCT05322083 -
HIV A6 Genome In ART Unsuccessful Patients On DOR
|
||
| Completed |
NCT04772469 -
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
|
N/A | |
| Terminated |
NCT02898896 -
Coronary Artery Disease (CAD) in Suppressed HIV-infected
|
N/A | |
| Completed |
NCT03671291 -
Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV
|
N/A |